EZH2 and glioblastoma: DNMT1 and MYC are two important oncogenes well described in GBM pathobiology, shown to function in association with EZH231,32 and their expression appears to be dependent on the combined activity of EZH2, BMI1, and LSD1 (Supplementary Fig. 11).